Navigation Links
Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
Date:2/25/2013

Davis, CA (PRWEB) February 25, 2013

Marrone Bio Innovations, Inc. (MBI), a leading global provider of natural pest management products for the agricultural and water treatment markets, announces the submission of a new bioherbicide, MBI-011 EP, to the U. S. Environmental Protection Agency (EPA). This is the second bioherbicide MBI has submitted for approval to the EPA (MBI-005 bioherbicide was EPA-approved in 2012). MBI-011 EP is a post-emergent burndown herbicide that can also be used as a crop desiccant. It has contact activity and no post-application planting restrictions are expected. MBI-011 EP is being submitted for control of annual and perennial grass and broadleaf weeds in the agricultural, non-crop and consumer home and garden markets.

Dr. Phyllis Himmel, MBI vice president of research and development, noted how the product got its start when one of MBI’s chemists screened for herbicidal activity of medicinal herbs. During the testing of 350 different herbs, an extract of dry long pepper (Piper longum L.) fruits showed activity against lettuce seedlings. This active ingredient was identified as sarmentine, a naturally occurring compound that gives black pepper its pungent aroma.

The new bioherbicide offers broad-spectrum control and will provide an alternative to herbicides that are highly prone to resistance. According to the International Survey of Herbicide Resistant Weeds, weeds have developed resistance to 148 different herbicides in 63 crops in 61 countries. “With the continuing and widespread identification of herbicide resistant weeds, we are very excited about submitting this product for registration,” remarks Dr. Pam Marrone, CEO. “It has become increasingly clear that no one product can be the ultimate solution to a weed problem and herbicide users need an array of tools to combat weeds. One of the most important benefits we provide users of all our biopesticide products is helping them strengthen their Integrated Resistance Management (IRM) programs. With our new herbicide, we believe we are making a positive contribution in this area.”

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. is a leading global provider of biopesticides for the agricultural market. Its effective, natural products provide higher crop yields and quality while managing pest resistance and residues. MBI has developed a pipeline of products including several nematicide, fungicide, algaecide and plant health product candidates. The award-winning MBI products for the ag market include Regalia® biofungicide and Grandevo®, a broad-spectrum bioinsecticide. The company recently received EPA approval for Opportune™, a novel bioherbicide and submitted Venerate™, a broad-spectrum contact insecticide discovered through the MBI screening process. MBI currently has more than three dozen patents pending in the U.S. and globally.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10461667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations’ Zequanox® Demonstrates Control of Zebra Mussels in Illinois Lake
2. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
3. Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
4. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
5. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
6. Prism Awards Honor Innovations in ‘Ubiquitous’ Photonics Technology
7. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
8. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
9. The Scientist Proudly Announces the Top 10 Innovations of 2012
10. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at Twease.org
11. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... journal has concluded that “in the setting of previously treated, advanced pancreatic cancer, ... in defining the optimal patient population and timing of blood sampling may improve ...
(Date:12/7/2016)... /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company ... products for the treatment of cancer, today announced ... Development Program with Cytovance Biologics ( Oklahoma ... antibody product. Supported by recent positive interim clinical ... ovarian cancer patients, OncoQuest has engaged Cytovance to ...
(Date:12/7/2016)... -- Biocom, the association for the California ... 21 st Century Cures legislation in Congress. The bill ... vote and in the Senate on December 7 by a ... Panetta , president & CEO of Biocom: "Today, ... of patients around the world. The measure culminates three years ...
(Date:12/7/2016)... 2016  Genprex, Inc. a biopharmaceutical company focused ... today announced that it has retained ICR Healthcare, ... communications and advisory firm, to develop and implement ... combine investor relations, public relations and digital communications ... of Genprex and its lead candidate Oncoprex, which ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016 BioCatch , the global leader ... patent portfolio, which grew to over 40 granted and pending patents. ... , , ... entitled " System, Device, and Method Estimating Force Applied to ... makers to forego costly hardware components needed to estimate the force and ...
(Date:12/6/2016)... Dec. 6, 2016 Valencell , the leading ... has seen a third consecutive year of triple digit ... in 2016 with a 360 percent increase in companies ... increase was driven by sales of its wrist and ... in its technology for hearables for fitness and healthcare ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
Breaking Biology News(10 mins):